Metabolism is fundamental to the survival of cancer cells, providing them with the energy and molecular components necessary for rapid growth and division. In many cancers, metabolic processes are altered, often favoring glycolysis even in the presence of oxygen, a phenomenon known as the Warburg effect. This shift allows cancer cells to thrive in oxygen-poor environments. Researchers are investigating how these metabolic alterations can be targeted to disrupt the growth of tumors. By targeting key enzymes or pathways involved in cancer cell metabolism, scientists hope to develop therapies that can inhibit tumor growth, potentially improving outcomes when combined with existing treatments like chemotherapy and radiation.